BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31096047)

  • 1. Kinase activity of casein kinase 1 delta (CK1δ) is modulated by protein kinase C α (PKCα) by site-specific phosphorylation within the kinase domain of CK1δ.
    Meng Z; Böhm T; Xu P; Henne-Bruns D; Peifer C; Witt L; Knippschild U; Bischof J
    Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):710-721. PubMed ID: 31096047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CK1δ kinase activity is modulated by protein kinase C α (PKCα)-mediated site-specific phosphorylation.
    Meng Z; Bischof J; Ianes C; Henne-Bruns D; Xu P; Knippschild U
    Amino Acids; 2016 May; 48(5):1185-97. PubMed ID: 26803658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinase domain of CK1δ can be phosphorylated by Chk1.
    Böhm T; Meng Z; Haas P; Henne-Bruns D; Rachidi N; Knippschild U; Bischof J
    Biosci Biotechnol Biochem; 2019 Sep; 83(9):1663-1675. PubMed ID: 31094292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of CK1delta: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo.
    Giamas G; Hirner H; Shoshiashvili L; Grothey A; Gessert S; Kühl M; Henne-Bruns D; Vorgias CE; Knippschild U
    Biochem J; 2007 Sep; 406(3):389-98. PubMed ID: 17594292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CK1δ activity is modulated by CDK2/E- and CDK5/p35-mediated phosphorylation.
    Ianes C; Xu P; Werz N; Meng Z; Henne-Bruns D; Bischof J; Knippschild U
    Amino Acids; 2016 Feb; 48(2):579-92. PubMed ID: 26464264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CK1δ kinase activity is modulated by Chk1-mediated phosphorylation.
    Bischof J; Randoll SJ; Süßner N; Henne-Bruns D; Pinna LA; Knippschild U
    PLoS One; 2013; 8(7):e68803. PubMed ID: 23861943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs.
    Knippschild U; Milne DM; Campbell LE; DeMaggio AJ; Christenson E; Hoekstra MF; Meek DW
    Oncogene; 1997 Oct; 15(14):1727-36. PubMed ID: 9349507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific phosphorylation of casein kinase 1 δ (CK1δ) regulates its activity towards the circadian regulator PER2.
    Eng GWL; Edison ; Virshup DM
    PLoS One; 2017; 12(5):e0177834. PubMed ID: 28545154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression levels of Casein kinase 1 (CK1) isoforms are correlated to adiponectin levels in adipose tissue of morbid obese patients and site-specific phosphorylation mediated by CK1 influences multimerization of adiponectin.
    Xu P; Fischer-Posovszky P; Bischof J; Radermacher P; Wabitsch M; Henne-Bruns D; Wolf AM; Hillenbrand A; Knippschild U
    Mol Cell Endocrinol; 2015 May; 406():87-101. PubMed ID: 25724478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein phosphatase 2A is regulated by protein kinase Cα (PKCα)-dependent phosphorylation of its targeting subunit B56α at Ser41.
    Kirchhefer U; Heinick A; König S; Kristensen T; Müller FU; Seidl MD; Boknik P
    J Biol Chem; 2014 Jan; 289(1):163-76. PubMed ID: 24225947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKCα and PKCδ activation regulates transcriptional activity and degradation of progesterone receptor in human astrocytoma cells.
    González-Arenas A; Peña-Ortiz MÁ; Hansberg-Pastor V; Marquina-Sánchez B; Baranda-Ávila N; Nava-Castro K; Cabrera-Wrooman A; González-Jorge J; Camacho-Arroyo I
    Endocrinology; 2015 Mar; 156(3):1010-22. PubMed ID: 25514083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of Casein Kinase 1 Delta Promotes Genomic Instability - The Accumulation of DNA Damage and Down-Regulation of Checkpoint Kinase 1.
    Greer YE; Gao B; Yang Y; Nussenzweig A; Rubin JS
    PLoS One; 2017; 12(1):e0170903. PubMed ID: 28125685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autokinase Activity of Casein Kinase 1 δ/ε Governs the Period of Mammalian Circadian Rhythms.
    Guo G; Wang K; Hu SS; Tian T; Liu P; Mori T; Chen P; Johnson CH; Qin X
    J Biol Rhythms; 2019 Oct; 34(5):482-496. PubMed ID: 31392916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalytic activity of protein kinase CK1 delta (casein kinase 1delta) is essential for its normal subcellular localization.
    Milne DM; Looby P; Meek DW
    Exp Cell Res; 2001 Feb; 263(1):43-54. PubMed ID: 11161704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Characterization of CK1δ-Mediated Tau Phosphorylation in Alzheimer's Disease.
    Roth A; Sander A; Oswald MS; Gärtner F; Knippschild U; Bischof J
    Front Mol Biosci; 2022; 9():872171. PubMed ID: 36203870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fuzzy interactions between the auto-phosphorylated C-terminus and the kinase domain of CK1δ inhibits activation of TAp63α.
    Lambert M; Gebel J; Trejtnar C; Wesch N; Bozkurt S; Adrian-Allgood M; Löhr F; Münch C; Dötsch V
    Sci Rep; 2023 Sep; 13(1):16423. PubMed ID: 37777570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of casein kinase 1 delta (CK1 delta) with the light chain LC2 of microtubule associated protein 1A (MAP1A).
    Wolff S; Xiao Z; Wittau M; Süssner N; Stöter M; Knippschild U
    Biochim Biophys Acta; 2005 Sep; 1745(2):196-206. PubMed ID: 15961172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase Cδ but not PKCα is involved in insulin-induced glucose metabolism in hepatocytes.
    Brutman-Barazani T; Horovitz-Fried M; Aga-Mizrachi S; Brand C; Brodie C; Rosa J; Sampson SR
    J Cell Biochem; 2012 Jun; 113(6):2064-76. PubMed ID: 22271577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients.
    Richter J; Ullah K; Xu P; Alscher V; Blatz A; Peifer C; Halekotte J; Leban J; Vitt D; Holzmann K; Bakulev V; Pinna LA; Henne-Bruns D; Hillenbrand A; Kornmann M; Leithäuser F; Bischof J; Knippschild U
    Int J Cancer; 2015 Jun; 136(12):2799-810. PubMed ID: 25404202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.
    Liu C; Witt L; Ianes C; Bischof J; Bammert MT; Baier J; Kirschner S; Henne-Bruns D; Xu P; Kornmann M; Peifer C; Knippschild U
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.